McKinsey Drove Opioid Sale Scheme, Endo Ch. 11 Trust Says

By Clara Geoghegan · August 16, 2024, 7:51 PM EDT

Consulting giant McKinsey & Co. should pay at least $1.5 billion to cover costs pharmaceutical developer Endo International racked up defending against claims that it helped drive the opioid crisis, an...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login